However, recent data indicate that the two cytochrome isoenzymes CYP2J2 and CYP4F2 metabolize linezolid [17] which may be influenced by liver failure and thus could explain the reduced body clearance in ACLF as shown in our study. The gene discussed is CYP4F2; the disease is liver failure.